Merck expands M Lab collaboration center in Shanghai with additional €14 M investment

Merck, a leading science and technology company, has expanded its M Lab Collaboration Center in Shanghai, the company’s largest in its global network of ten interconnected labs. The €14 million investment adds a new biology application lab, a process development training center and an upstream application lab to the existing M Lab Collaboration Center in Shanghai.

Opened in 2020 and strategically located in Pudong, at the heart of the biomedical park in Shanghai, the M Lab Collaboration Center offers customizable solutions tailored for China’s life science community to help advance drug development. It includes Pilot Scale and Process Development support labs that offer non-GMP (Good Manufacturing Practice) lab space where pharmaceutical and biopharmaceutical manufacturers can explore ideas, learn techniques and work side-by-side with the company’s scientists and engineers to solve critical process development and production challenges.

Customers can participate in product demonstrations, hands-on training, formal bioprocessing educational courses and experiments, and apply best practices and new approaches to develop, optimise and scale-up processes.

The Center houses 14 labs from the M Lab Collaboration Center and several labs from the BioRelliance Biologics Testing Center opened in 2022.